The ASAM Appropriate Use of Drug Testing in Clinical Addiction Medicine Webinar (1 CME)
This webinar helps build knowledge of The ASAM Appropriate Use of Drug Testing in Clinical Addiction Medicine document, which guides provider decisions about drug testing, as no universal standard exists today. It will allow providers, patients and their families, healthcare administrators, and payers determine clearly what is appropriate practice and what is considered outside the realm of appropriate practice in regard to drug testing in clinical addiction medicine. This webinar is primarily intended for addiction specialists and all providers utilizing drug testing in the context of the identification, diagnosis, treatment, and monitoring of patients with, or at risk for, addiction. It will also be useful for physicians and other providers concerned about the possibility of addiction in their patient population.
Louis E. Baxter, Sr.
Dr. Louis E. Baxter, Sr., MD, DFASAM is a Past ASAM President and is the President &CEO of thr Professional Assistance Program of New Jersey, Inc.
Dr. Baxter is a certified in Addiction Medicine by the American Board of Addiction Medicine and formerly served on the Board of Directors. Dr. Baxter has served and chaired many government advisory committees and panels which include SAMHSA, NIDA, CSAT, NIAAA, and a Presidential Advisor through ONDCP since the Clinton Administration.
Dr. Baxter has served the State of New Jersey in various capacities serving on the Governor's Council for Drug and Alcohol Addiction, Medical Director for the Division of Addiction Services, and most recently as the Addiction Medicine Consultant for the Division of Mental Health and Addiction Services. He has held academic appointments as Assistant Clinical Professor of Medicine for former University Medicine & Dentistry and now currently with Rutgers New Jersey Medical School in Newark, NJ. Dr. Baxter is serving as Co-Director if the Addiction Medicine Fellowship Program at Howard University Medical School and Hospital.
Upon completion of this activity, participants should be able to:
-Recognize the importance of the guidance needed around drug testing today
-Identify the fundamental components of drug testing in a clinical setting
-Summarize the document's recommendations and discuss how they should be used in practice
-Address common clinical questions around drug testing in a clinical setting